Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05565599 · ClinicalTrials.gov registry record · NA
An Early Feasibility Study Evaluating the Safety and Efficacy of the Laminar Left Atrial Appendage Closure System in Subjects With Non-Valvular Atrial Fibrillation
A NA study of Non-valvular Atrial Fibrillation, sponsored by Biosense Webster.
- Active
- Registry status
- NA
- Development phase
- 45
- Enrollment target
- 7
- Study locations
NCT05565599 is a NA study of Non-valvular Atrial Fibrillation that is active but no longer recruiting, run by Biosense Webster. The registered enrollment target is 45 participants. The trial reports 7 study locations across 4 states.
The verdict
NCT05565599, a NA study of Non-valvular Atrial Fibrillation, is active but no longer recruiting, sponsored by Biosense Webster.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
- 7
- Study locations
Study Summary
This is an early feasibility study is to evaluate the safety and effectiveness of the Laminar Left Atrial Appendage Closure System to treat patients with non-valvular atrial fibrillation that cannot take, or a have a reason to seek an alternative, to anticoagulant medications.
Conditions Studied
Interventions
- DEVICE Left Atrial Appendage Closure
Study Locations (7)
California
- Scripps Health - La Jolla
- UC Davis Medical Center - Sacramento
- Los Robles Hospital & Medical Center - Thousand Oaks
New York
- The Mount Sinai Hospital - New York
- Columbia U. Medical Center / NY Presbyterian Hospital - New York
Arizona
- Tucson Medical Center - Tucson
Arkansas
- St. Bernards Medical Center - Jonesboro
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2022-10-21 |
| Est. Completion | 2029-09-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05565599
The ClinicalTrials.gov registry entry for NCT05565599 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Biosense Webster, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Non-valvular Atrial Fibrillation appearing as the primary indexed condition, and to 1 intervention - of which Left Atrial Appendage Closure is the first listed.
NCT05565599 reports 7 study locations spanning 4 distinct geographic areas - top geographies include California, New York, Arizona.
Frequently Asked Questions
What is clinical trial NCT05565599 about?
NCT05565599 is a clinical study titled "An Early Feasibility Study Evaluating the Safety and Efficacy of the Laminar Left Atrial Appendage Closure System in Subjects With Non-Valvular Atrial Fibrillation". This is an early feasibility study is to evaluate the safety and effectiveness of the Laminar Left Atrial Appendage Closure System to treat patients with non-valvular atrial fibrillation that cannot take, or a have a reason to seek an alternative, to anticoagulant medications.
What is the current status of trial NCT05565599?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 45 participants. The study started on 2022-10-21. Estimated completion is 2029-09-01.
What conditions does trial NCT05565599 study?
This clinical trial studies the following conditions: Non-valvular Atrial Fibrillation.
What interventions are being tested in trial NCT05565599?
The interventions under investigation include: Left Atrial Appendage Closure (DEVICE).
Who is sponsoring clinical trial NCT05565599?
This trial is sponsored by Biosense Webster, which has 18 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05565599 being conducted?
This trial has 7 study locations across Arizona, Arkansas, California, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Non-valvular Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.